1)本橋伸高,粟田主一,一瀬邦弘,他:電気けいれん療法(ECT)推奨事項 改訂版.精神経誌 115:586-600, 2013
2)UK ECT Review Group:Efficacy and safety of electroconvulsive therapy in depressive disorders:a systematic review and meta-analysis. Lancet 361:799-808, 2003
3)Elias A, Thomas N, Sackeim HA:Electroconvulsive Therapy in mania:a review of 80 years of clinical experience. Am J Psychiatry 178:229-239, 2021
4)Sackeim HA, Rush AJ:Melancholia and response to ECT. Am J Psychiatry 152:1242-1243, 1995
5)日本うつ病学会気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドラインⅡ.うつ病(DSM-5)/大うつ病性障害,2016
6)Husain MM, Rush AJ, Fink M, et al:Speed of response and remission in major depressive disorder with acute electroconvulsive therapy(ECT):a Consortium for Research in ECT(CORE)report. J Clin Psychiatry 65:485-491, 2004
7)Kellner CH, Fink M, Knapp R, et al:Relief of expressed suicidal intent by ECT:a Consortium for Research in ECT study. Am J Psychiatry 162:977-982, 2005
8)Rothschild AJ:Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am 19:237-252, 1996
9)日本うつ病学会気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドライン—高齢者のうつ病治療ガイドライン,2020
10)Dong M, Zhu XM, Zheng W, et al:Electroconvulsive therapy for older adult patients with major depressive disorder:a systematic review of randomized controlled trials. Psychogeriatrics 18:468-475, 2018
11)van der Wurff FB, Stek ML, Hoogendijk WJ, et al:The efficacy and safety of ECT in depressed older adults:a literature review. Int J Geriatr Psychiatry 18:894-904, 2003
12)Milev RV, Giacobbe P, Kennedy SH, et al:CANMAT Depression Work Group:Canadian Network for Mood and Anxiety Treatments(CANMAT)2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder:Section 4. Neurostimulation Treatments. Can J Psychiatry 61:561-575, 2016
13)Jelovac A, Kolshus E, McLoughlin DM:Relapse following successful electroconvulsive therapy for major depression:a meta-analysis. Neuropsychopharmacology 38:2467-2474, 2013
14)National Collaborating Centre for Mental Health(UK):Depression:The Treatment and Management of Depression in Adults(Updated Edition). British Psychological Society, Leicester, 2010
15)日本うつ病学会気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドラインⅠ.双極性障害,2020
16)Yatham LN, Kennedy SH, Parikh SV, et al:Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 20:97-170, 2018
17)Fountoulakis KN, Grunze H, Vieta E, et al:The International College of Neuro-Psychopharmacology(CINP)Treatment Guidelines for Bipolar Disorder in Adults(CINP-BD-2017), Part 3:The Clinical Guidelines. Int J Neuropsychopharmacol 20:180-195, 2017
18)National Collaborating Centre for Mental Health(UK):Bipolar Disorder:The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. The British Psychological Society and The Royal College of Psychiatrists, London, 2014
19)Bahji A, Hawken ER, Sepehry AA, et al:ECT beyond unipolar major depression:systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand 139:214-226, 2019
20)Popiolek K, Bejerot S, Brus O, et al:Electroconvulsive therapy in bipolar depression-effectiveness and prognostic factors. Acta Psychiatr Scand 140:196-204, 2019
21)Sundsted KK, Burton MC, Shah R, et al:Preanesthesia medical evaluation for electroconvulsive therapy:a review of the literature. J ECT 30:35-42, 2014
22)和田健:患者・家族用パンフレット.日本精神神経学会ECT・rTMS等検討委員会編:ECTグッドプラクティス—安全で効果的な治療を目指して.新興医学出版社,pp227-229,2020
23)Sienaert P, Roelens Y, Demunter H, et al:Concurrent use of lamotrigine and electroconvulsive therapy. J ECT 27:148-152, 2011
24)Dolenc TJ, Rasmussen KG:The safety of electroconvulsive therapy and lithium in combination:a case series and review of the literature. J ECT 21:165-170, 2005
25)諏訪太朗,安田和幸,川島啓嗣,他:電気けいれん療法における発作誘発困難例と200%機器について—対応法に関する現況調査と文献レビュー.総合病院精神医学(印刷中)
26)Eda M, Matsuki R:When to switch from bilateral to unilateral electroconvulsive therapy:a simple way to elicit seizures in high seizure threshold cases. Neuropsychopharmacol Rep 39:36-40, 2019